These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38444259)

  • 1. Okur-Chung neurodevelopmental syndrome: Implications for phenotype and genotype expansion.
    Nan H; Chu M; Zhang J; Jiang D; Wang Y; Wu L
    Mol Genet Genomic Med; 2024 Mar; 12(3):e2398. PubMed ID: 38444259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur-Chung neurodevelopmental syndrome.
    Blanc A; Bonnet C; Wandzel M; Roth V; Duffourd Y; Safraou H; Leheup B; Muller F; D Colne J; Feillet F; Schmitt E; Castro M; Savatt J; Burcheri A; Nemos C; Philippe C; Lambert L
    Am J Med Genet A; 2024 Sep; 194(9):e63642. PubMed ID: 38711237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient organization perspective: a research roadmap for Okur-Chung Neurodevelopmental Syndrome.
    Rushing GV; Sills J
    Ther Adv Rare Dis; 2024; 5():26330040241249763. PubMed ID: 39070093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of Okur-Chung syndrome caused by CSNK2A1 gene variation and review of literature].
    Duan HL; Peng J; Pang N; Chen SM; Xiong J; Guang SQ; Yin F
    Zhonghua Er Ke Za Zhi; 2019 May; 57(5):368-372. PubMed ID: 31060130
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Features of Okur-Chung Neurodevelopmental Syndrome: Case Report and Literature Review.
    Jafari Khamirani H; Zoghi S; Motealleh A; Dianatpour M; Tabei SMB; Mohammadi S; Dastgheib SA
    Mol Syndromol; 2022 Dec; 13(5):381-388. PubMed ID: 36588763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Okur-Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion.
    Chiu ATG; Pei SLC; Mak CCY; Leung GKC; Yu MHC; Lee SL; Vreeburg M; Pfundt R; van der Burgt I; Kleefstra T; Frederic TM; Nambot S; Faivre L; Bruel AL; Rossi M; Isidor B; Küry S; Cogne B; Besnard T; Willems M; Reijnders MRF; Chung BHY
    Clin Genet; 2018 Apr; 93(4):880-890. PubMed ID: 29240241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual molecular diagnosis of tricho-rhino-phalangeal syndrome type I and Okur-Chung neurodevelopmental syndrome in one Chinese patient: a case report.
    Xu S; Lian Q; Wu J; Li L; Song J
    BMC Med Genet; 2020 Aug; 21(1):158. PubMed ID: 32746809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Okur-Chung Neurodevelopmental Syndrome with a Novel, de novo Variant on the
    Zhuri D; Dusenkalkan F; Tunca Alparslan G; Gurkan H
    Mol Syndromol; 2024 Feb; 15(1):43-50. PubMed ID: 38357263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel
    Wu RH; Tang WT; Qiu KY; Li XJ; Tang DX; Meng Z; He ZW
    J Int Med Res; 2021 May; 49(5):3000605211017063. PubMed ID: 34038195
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent Hyperplastic Primary Vitreous with Microphthalmia and Coloboma in a Patient with Okur-Chung Neurodevelopmental Syndrome.
    Murakami H; Uehara T; Enomoto Y; Nishimura N; Kumaki T; Kuroda Y; Asano M; Aida N; Kosaki K; Kurosawa K
    Mol Syndromol; 2022 Feb; 13(1):75-79. PubMed ID: 35221879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.
    Dominguez I; Cruz-Gamero JM; Corasolla V; Dacher N; Rangasamy S; Urbani A; Narayanan V; Rebholz H
    Hum Genet; 2021 Jul; 140(7):1077-1096. PubMed ID: 33944995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending the phenotype associated with the CSNK2A1-related Okur-Chung syndrome-A clinical study of 11 individuals.
    Owen CI; Bowden R; Parker MJ; Patterson J; Patterson J; Price S; Sarkar A; Castle B; Deshpande C; Splitt M; Ghali N; Dean J; Green AJ; Crosby C; ; Tatton-Brown K
    Am J Med Genet A; 2018 May; 176(5):1108-1114. PubMed ID: 29383814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Okur-Chung neurodevelopmental syndrome in a patient from Spain.
    Martinez-Monseny AF; Casas-Alba D; Arjona C; Bolasell M; Casano P; Muchart J; Ramos F; Martorell L; Palau F; García-Alix A; Serrano M
    Am J Med Genet A; 2020 Jan; 182(1):20-24. PubMed ID: 31729156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of a novel de novo variant of CSNK2A1 gene in a boy with Okur-Chung neurodevelopmental syndrome].
    Wu R; Tang W; Liang L; Li X; Ouyang N; Meng Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jun; 37(6):641-644. PubMed ID: 32472542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited CSNK2A1 variants in families with Okur-Chung neurodevelopmental syndrome.
    Belnap N; Price-Smith A; Ramsey K; Leka K; Abraham A; Lieberman E; Hassett K; Potu S; Rudy N; Smith K; Mikhail FM; Monaghan KG; Hendershot A; Mourmans J; Descartes M; Huentelman MJ; Sills J; Rangasamy S; Narayanan V
    Clin Genet; 2023 Nov; 104(5):607-609. PubMed ID: 37491870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive functional, statistical and structural analysis of
    Unni P; Friend J; Weinberg J; Okur V; Hochscherf J; Dominguez I
    Front Mol Biosci; 2022; 9():851547. PubMed ID: 36310603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel CSNK2A1 variants associated with mild Okur-Chung neurodevelopmental syndrome phenotype.
    Wafik M; Kuoppamaa H; Hirani P; Hignett J; Lillis S; Lascelles K; Sardesai S; Gomez K; Holder-Espinasse M
    Clin Dysmorphol; 2023 Jul; 32(3):116-123. PubMed ID: 37195306
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparing Two Neurodevelopmental Disorders Linked to CK2: Okur-Chung Neurodevelopmental Syndrome and Poirier-Bienvenu Neurodevelopmental Syndrome-Two Sides of the Same Coin?
    Ballardin D; Cruz-Gamero JM; Bienvenu T; Rebholz H
    Front Mol Biosci; 2022; 9():850559. PubMed ID: 35693553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.